Free Trial

Acura Pharmaceuticals (ACUR) SEC Filings & 10K Form

Acura Pharmaceuticals logo
$0.0020 0.00 (0.00%)
(As of 11/21/2024 ET)

Recent Acura Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/04/2024
2:00 PM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
10:16 AM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
1:44 PM
Acura Pharmaceuticals (Filer)
Form NT 10-Q
07/26/2024
2:52 PM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
1:58 PM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
10:00 AM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:00 AM
Acura Pharmaceuticals (Filer)
Form NT 10-Q
05/14/2024
3:40 PM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:00 AM
Acura Pharmaceuticals (Filer)
Form NT 10-K
03/26/2024
12:06 PM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
9:53 AM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
9:27 AM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
4:13 PM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
2:20 PM
Acura Pharmaceuticals (Issuer)
WESSON BRUCE F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
2:20 PM
Acura Pharmaceuticals (Issuer)
THANGARAJ IMMANUEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
2:23 PM
Acura Pharmaceuticals (Issuer)
SKELLY WILLIAM G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
2:23 PM
Acura Pharmaceuticals (Issuer)
ROSS GEORGE K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
11:01 AM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
1:35 PM
Acura Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:ACUR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners